Efficient growth suppression in pancreatic cancer PDX model by fully human anti-mesothelin CAR-T cells

被引：21
|
作者：
Jiang, Hua [1 ]
Song, Bo [2 ]
Wang, Peng [2 ]
Shi, Bizhi [1 ]
Li, Qixiang [3 ]
Fan, Mingliang [1 ]
Di, Shengmeng [1 ]
Yang, Jie [4 ]
Li, Zonghai [1 ,2 ]
机构：
[1] Shanghai Jiao Tong Univ, Sch Med, State Key Lab Oncogenes & Related Genes, Shanghai Canc Inst,Renji Hosp, Shanghai 200032, Peoples R China
[2] CARsgen Therapeut, Shanghai 200231, Peoples R China
[3] Crown Biosci Inc, Sci Technol Innovat Pk, Taicang City 215400, Peoples R China
[4] Shanghai Blood Ctr, Blood Engn Lab, Shanghai 200051, Peoples R China
来源：
PROTEIN & CELL | 2017年 / 8卷 / 12期
基金：
中国国家自然科学基金;
关键词：
D O I：
10.1007/s13238-017-0472-9
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
引用
收藏
页码：926 / 931
页数：6
相关论文
共 50 条
  • [31] ZFP36 disruption is insufficient to enhance the function of mesothelin-targeting human CAR-T cells
    David Mai
    Tifara Boyce
    Aakash Mehta
    Jordan Reff
    John Scholler
    Neil C. Sheppard
    Carl H. June
    [J]. Scientific Reports, 14
  • [32] Anti-HER-2 Chimeric Antigen Receptor T (CAR-T) Cells Immunotherapy for Pancreatic Cancer: An Innovative Surgically Derived Tumor Spheroid Model
    Orbach, Lior
    Loewenstein, Shelly
    Lerman, Veronika
    Vaskovich, Daniella
    Kleiner, Ron
    Levin, Anat Globerson
    Satchi-Fainaro, Ronit
    Lahat, Guy
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2024, 31 (01) : S27 - S28
  • [33] Anti-cancer drugs induce senescence in cancer cells and increase their sensitivity to CAR-T cells
    Harada, Mamoru
    Okimoto, Tamio
    Inao, Touko
    Tanino, Ryosuke
    Iida, Yuichi
    Kotani, Hitoshi
    Isobe, Takeshi
    [J]. CANCER SCIENCE, 2018, 109 : 1270 - 1270
  • [34] EGFRvIII-specific CAR-T cells produced by piggyBac transposon exhibit efficient growth suppression against hepatocellular carcinoma
    Ma, Yuan
    Chen, Yan
    Yan, Lei
    Cao, Hui-Xia
    Han, Shuang-Yin
    Cui, Jun -Jun
    Wen, Jian Guo
    Zheng, Yan
    [J]. INTERNATIONAL JOURNAL OF MEDICAL SCIENCES, 2020, 17 (10): : 1406 - 1414
  • [35] Efficient Systemic Treatment With Mesothelin-Targeted Oncolytic Adenovirus in Patient- Derived Xenograft (PDX) Model of Pancreatic Cancer
    Sato-Dahlman, M.
    Hajeri, P.
    Yoshida, H.
    Jacobsen, K.
    Yanagiba, C.
    Yamamoto, M.
    [J]. PANCREAS, 2018, 47 (10) : 1421 - 1421
  • [36] Efficient Systemic Treatment with Mesothelin-Targeted Oncolytic Adenovirus in Patient-Derived Xenograft (PDX) Model of Pancreatic Cancer
    Sato-Dahlman, Mizuho
    Miura, Yoshiaki
    Hajeri, Praveensingh
    Yoshida, Hideki
    Jacobsen, Kari
    Yanagiba, Chikako
    Yamamoto, Masato
    [J]. MOLECULAR THERAPY, 2018, 26 (05) : 330 - 330
  • [37] Intra-tumor persistence of activated anti-mesothelin hYP218 CAR T cells is associated with increased efficacy in gastric and colorectal cancers
    Mir, Sameer A.
    Venugopalan, Abhilash
    Zhang, Jingli
    Khanal, Mana Kamana
    Stathopoulou, Chaido
    Sengupta, Manjistha
    Jiang, Qun
    Hassan, Raffit
    [J]. CANCER RESEARCH, 2024, 84 (06)
  • [38] Potent antitumor efficacy of anti-LunX CAR-T cells in lung cancer
    Hu, Z.
    Zheng, X.
    Sun, R.
    Tian, Z.
    Wei, H.
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 2019, 49 : 1715 - 1716
  • [39] Early administration of amatuximab, a chimeric high-affinity anti-mesothelin monoclonal antibody, suppresses liver metastasis of mesothelin-expressing pancreatic cancer cells and enhances gemcitabine sensitivity in a xenograft mouse model
    Fujii, Yuki
    Kamachi, Hirofumi
    Matsuzawa, Fumihiko
    Mizukami, Tatsuzo
    Kobayashi, Nozomi
    Fukai, Moto
    Taketomi, Akinobu
    [J]. INVESTIGATIONAL NEW DRUGS, 2021, 39 (05) : 1256 - 1266
  • [40] The exosomes derived from CAR-T cell efficiently target mesothelin and reduce triple-negative breast cancer growth
    Yang, Pengxiang
    Cao, Xingjian
    Cai, Huilong
    Feng, Panfeng
    Chen, Xiang
    Zhu, Yihua
    Yang, Yue
    An, Weiwei
    Yang, Yumin
    Jie, Jing
    [J]. CELLULAR IMMUNOLOGY, 2021, 360
12345